Peter Wehrwein has been the lead editor of Managed Healthcare Executive since February 2020.
Another Dispatch From the Accumulator-Maximizer Wars
June 1st 2023Vanderbilt’s Stacie Dusetzina and colleagues explain how the ‘copay adjustment’ programs work in this week’s JAMA Internal Medicine and also shed light on third strategy used by insurers and pharmaceutical benefit managers, the alternative payment program.
Read More
Some Years of Progress in Narrowing Black-White Mortality Differences. Then COVID-19 Happened
May 17th 2023Results reported in JAMA comparing Black and White populations show a narrowing and then leveling off of excess mortality and potential years of life lost before the difference widened again in 2020.
Read More
Medicaid Redetermination, Sanders' Healthcare $$$ Plans & AI for Mental Health | The AM News Cycle
May 17th 2023Medicaid redetermination may result in a favorable payer mix for some providers if people switch to ACA and employer-based coverage that has higher payer rates. But that is a pretty big if.
Read More
Oxygen for Newborns: When There Is Too Much of a Necessary Thing
May 11th 2023Oxygen supplementation may be necessary, especially for newborns born prematurely. But the oxygen free radicals associated with high levels can be harmful, causing conditions such as retinopathy of prematurity, which can result in blindness. A review article discusses how researchers and clinicians have found the right balance between high and low oxygen supplementation for newborns.
Read More
The Healthcare World According to Fein | 2023 Asembia Specialty Pharmacy Summit
May 3rd 2023Adam Fein, Ph.D., talked about some surprising trends in specialty pharmacy and healthcare at the 2023 Asembia Specialty Pharmacy Summit. The number of specialty pharmacy locations may be peaking. And that "gross-to-net bubble" in drug prices that Fein has written about so much — well, it may be shrinking.
Read More
A relatively small number of cell and gene therapies have become a clinical reality. But now the specialty pharmacy industry, and healthcare more generally, is bracing for a wave of cell and gene therapies that will force change and adaption. And, yes, the new therapies will be extremely costly.
Read More
Sleep Health Through the Disparities Lens
April 15th 2023The National Sleep Foundation published a position statement about disparities last year. Earlier this year, researchers reported findings showing that White patients with a diagnosis of insomnia are more likely to be prescribed an FDA-approved medication than Black patients.
Read More
A study in this month's Health Affairs shows that Medicare Advantage penetration has a ripple effect on the patterns of postacute care usage among those in traditional Medicare. As Medicare Advantage penetration increased, use of postacute care services by beneficiaries in traditional Medicare decreased.
Read More